OverT Bio, Inc. — Form D/A
OverT Bio, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2024-05-09. The offering totals $17.0M, of which $16.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-09
- Form: D/A
- Accession: 0001973901-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $16.0M
- Remaining: $1.0M
- Investors: 15
- Date of first sale: 2023-04-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480712
Issuer
- Name: OverT Bio, Inc.
- CIK: 0001973901
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 430 E 29TH ST 14FL, NEW YORK, NY, 10016
- Phone: 6463897709
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Vasudev Bailey | Director | New Yoprk City, NY |
| Sara Choi | Director | Palo Alto, CA |
| Mateusz Legut | Director | New York, NY |
| Neville Sanjana | Director | New York, NY |
| Mateusz Legut | Executive Officer | New York, NY |
Other filings by this issuer (1)
More